Skip to content

Gepotidacin

DRUG13 trials

Sponsors

GlaxoSmithKline, Institut National de la Santé Et de la Recherche Médicale, France

Conditions

GonorrheaHealthy VolunteersInfection, BacterialInfections, BacterialUrinary Tract Infections

Phase 1

Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
CompletedNCT02729038
GlaxoSmithKlineInfections, Bacterial
Start: 2016-06-29End: 2017-06-20Updated: 2020-07-21
Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function
CompletedNCT03562117
GlaxoSmithKlineInfections, Bacterial
Start: 2018-06-14End: 2018-12-26Updated: 2021-04-12
Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects
CompletedNCT04079790
GlaxoSmithKlineInfections, Bacterial
Start: 2019-09-04End: 2019-11-25Updated: 2020-09-04
Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue
CompletedNCT04484740
Institut National de la Santé Et de la Recherche Médicale, FranceGonorrhea, Infection, Bacterial
Start: 2021-01-29End: 2023-05-27Updated: 2025-02-20
Drug-drug Interaction Study of Gepotidacin
CompletedNCT04493931
GlaxoSmithKlineInfections, Bacterial
Start: 2020-08-14End: 2020-12-21Updated: 2022-03-04
A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants
CompletedNCT05271799
GlaxoSmithKlineHealthy Volunteers
Start: 2022-03-01End: 2022-04-22Updated: 2023-01-30
A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics
Not yet recruitingNCT07371429
GlaxoSmithKlineUrinary Tract Infections
Start: 2026-03-31End: 2027-08-23Target: 20Updated: 2026-02-12

Phase 2

Phase 3

Related Papers

4 more papers not shown